# A Phase I Trial of GW01-200 Tablets in Subjects With Advanced Tumors

> **NCT07629258** · PHASE1 · RECRUITING · sponsor: **Groovy Medicine (Hangzhou) Ltd.** · enrollment: 100 (estimated)

## Conditions studied

- Advanced Tumors

## Interventions

- **DRUG:** GW01-200

## Key facts

- **NCT ID:** NCT07629258
- **Lead sponsor:** Groovy Medicine (Hangzhou) Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-17
- **Primary completion:** 2029-01
- **Final completion:** 2029-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07629258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07629258, "A Phase I Trial of GW01-200 Tablets in Subjects With Advanced Tumors". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07629258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*